Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Twist Bioscience Corporation TWST
$11.91
-$0.74 (-6.22%)
На 18:01, 12 мая 2023
+185.47%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
726647796.00000000
-
week52high
58.76
-
week52low
11.46
-
Revenue
203565000
-
P/E TTM
-3
-
Beta
1.16552800
-
EPS
-3.87000000
-
Last Dividend
0.00000000
-
Next Earnings Date
05 мая 2023 г. в 12:00
Описание компании
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Market Perform | Market Perform | 08 авг 2022 г. |
| Barclays | Overweight | Overweight | 08 авг 2022 г. |
| Barclays | Overweight | Overweight | 13 июл 2022 г. |
| Barclays | Overweight | Overweight | 09 мая 2022 г. |
| Goldman Sachs | Neutral | Neutral | 13 апр 2022 г. |
| Barclays | Overweight | Overweight | 06 окт 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 07 окт 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 21 ноя 2022 г. |
| Barclays | Overweight | Overweight | 21 ноя 2022 г. |
| Baird | Outperform | Outperform | 21 ноя 2022 г. |
| Scotiabank | Sector Outperform | 05 янв 2023 г. | |
| Evercore ISI Group | Outperform | In-Line | 03 янв 2023 г. |
| Barclays | Overweight | Overweight | 30 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| THORBURN JAMES M | D | 51929 | 302 | 24 янв 2023 г. |
| Leproust Emily M. | D | 237609 | 980 | 24 янв 2023 г. |
| Finn Patrick John | D | 71933 | 337 | 24 янв 2023 г. |
| Green Paula | D | 22875 | 162 | 24 янв 2023 г. |
| Banyai William | D | 272382 | 232 | 24 янв 2023 г. |
| Banyai William | D | 272614 | 292 | 04 янв 2023 г. |
| THORBURN JAMES M | D | 52231 | 220 | 03 янв 2023 г. |
| THORBURN JAMES M | D | 52451 | 283 | 03 янв 2023 г. |
| Yankton Kevin Bruce | D | 10133 | 75 | 03 янв 2023 г. |
| Leproust Emily M. | D | 238589 | 490 | 03 янв 2023 г. |
Новостная лента
Twist Bioscience Corporation (TWST) Q2 2023 Earnings Call Transcript
Seeking Alpha
05 мая 2023 г. в 12:31
Twist Bioscience Corporation (NASDAQ:TWST ) Q2 2023 Earnings Conference Call May 5, 2023 8:00 AM ET Company Participants Angela Bitting - SVP, Corporate Affairs and ESG Officer Emily Leproust - CEO and Co-Founder James Thorburn - CFO Conference Call Participants Vijay Kumar - Evercore ISI Matt Larew - William Blair Steven Mah - Cowen Sung-Ji Nam - Scotiabank Luke Sergott - Barclays Puneet Souda - SVB Securities Tom Peterson - Baird Rachel Vatnsdal - JPMorgan Operator Good morning, ladies and gentlemen, and welcome to Twist Bioscience's Fiscal 2023 Second Quarter Financial Results Conference Call. [Operator Instructions] I would now like to turn the conference call over to Angela Bitting, Senior Vice President, Corporate Affairs and EGS Officer.
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Research
05 мая 2023 г. в 09:54
Twist Bioscience (TWST) came out with a quarterly loss of $1.06 per share versus the Zacks Consensus Estimate of a loss of $1.09. This compares to loss of $1.24 per share a year ago.
3 Growth Stocks Cathie Wood Just Bought That Could Be Absolute Game-Changers
The Motley Fool
02 мая 2023 г. в 05:53
Beam Therapeutics is a pioneer in base editing, an especially promising type of gene editing. CRISPR Therapeutics could soon bring the first CRISPR gene-editing therapy to market.
Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought
The Motley Fool
25 апр 2023 г. в 10:00
Cathie Wood bought shares of Roblox, Coinbase, and Twist Biosciences on Monday. Roblox is posting year-over-year growth, but profitability is still years away unless it can improve the monetization of its virtual realm.
The 7 Best Biotech Stocks for Personalized Medicine Investors
InvestorPlace
25 апр 2023 г. в 06:35
Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person's body.